IDH1 Mutations Are Associated with Favorable Outcomes in Prostate Cancer

Study limitation reported by the research below: “IDH1 inhibitors are not mentioned as a treatment in this study — the modality tag reflects the broader therapeutic relevance, not a tested intervention.”